V Vilin Bio Med Limited: directors' dealings · India · SEBI (PIT + SAST) SEBI:vilin-bio-med-limited IN IN · SEBI (PIT + SAST)
Explore the full directors' dealings record of Vilin Bio Med Limited, a publicly traded company based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). The latest transaction was filed on 30 December 2025 — Sale. Among the most active insiders: Venkata Rao Sadhanala. All data is free.
Last declaration on 30 December 2025
Declarations 14 total
Executives ● Sale0 SEBI
€39,872 207,957 shares @ €0.1917
Equity Shares
SEBI:e552b3604cd48f0d05dad92650d79b532a796671 · 29 Dec 2025
Executives ● Purchase0 SEBI
€39,872 207,957 shares @ €0.1917
Equity Shares
SEBI:a82d56303c821314a8657efd86304035c512ab58 · 29 Dec 2025
Ideal exit: 25 Sept 2026 (T+270) Executives ● Sale0 SEBI
€93,797 489,463 shares @ €0.1916
Equity Shares
SEBI:963813a4ccc94d22139b32614091f9146eafddb7 · 22 Dec 2025
Executives ● Purchase0 SEBI
€27,789 144,508 shares @ €0.1923
Equity Shares
SEBI:a23211066aa87694b83c6c548d50348c88944f59 · 24 Dec 2025
Ideal exit: 20 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€66,104 344,955 shares @ €0.1916
Equity Shares
SEBI:8e823c7f2bcad0969a47ebc7c94ffa16a9f48256 · 22 Dec 2025
Ideal exit: 18 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€85,202 445,130 shares @ €0.1914
Equity Shares
SEBI:a6e2750892d694649004da1c16612833a9c424c8 · 19 Dec 2025
Ideal exit: 15 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€141,290 738,000 shares @ €0.1914
Equity Shares
SEBI:0b07fd13d22007a4610be469e7259f5a4873bde1 · 12 Dec 2025
Ideal exit: 8 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€213,005 1,112,830 shares @ €0.1914
Equity Shares
SEBI:08806a29ed9b06eeca692cc1cb6747a2881f1a61 · 19 Dec 2025
Ideal exit: 15 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€141,290 738,000 shares @ €0.1914
Equity Shares
SEBI:25a63e76e94206d1e76c3a187db2996fb7a1158b · 12 Dec 2025
Ideal exit: 8 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€255,607 1,335,400 shares @ €0.1914
Equity Shares
SEBI:127bf1c4481edad248a89f65e3a55084e7565f33 · 19 Dec 2025
Ideal exit: 15 Sept 2026 (T+270) Executives ● Sale0 SEBI
€553,814 2,893,360 shares @ €0.1914
Equity Shares
SEBI:a18e5808d8e090f00a0075cc33b3649c47752d92 · 19 Dec 2025
Executives ● Sale0 SEBI
€553,814 2,893,360 shares @ €0.1914
Equity Shares
SEBI:b475b3a1d99b5b9cc2435c1f2857badf34c351f2 · 19 Dec 2025
Executives ● Sale0 SEBI
€141,290 738,000 shares @ €0.1914
Equity Shares
SEBI:e709b019ff8a38e8b48cdc4fdc124d1a07083754 · 12 Dec 2025
Executives ● Sale0 SEBI
€141,290 738,000 shares @ €0.1914
Equity Shares
SEBI:584da3adb789d8276a57f84b276ccc6aad41c65c · 12 Dec 2025